Xie XF, Wu NQ, Wu JF, Zhang GL, et al. CXCR4 inhibitor, AMD3100, down-regulates PARP1 expression and Synergizes with olaparib causing severe DNA damage in BRCA-proficient triple-negative breast cancer. Cancer Lett 2022 Oct 6:215944. doi: 10.1016/j.canlet.2022.215944.
PMID: 36209974